A detailed history of New Edge Advisors, LLC transactions in Nexgel, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 19,291 shares of NXGL stock, worth $61,731. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,291
Previous 1,808 966.98%
Holding current value
$61,731
Previous $3,000 1533.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.04 - $3.19 $35,665 - $55,770
17,483 Added 966.98%
19,291 $49,000
Q2 2024

Aug 15, 2024

BUY
$2.06 - $2.38 $688 - $794
334 Added 22.66%
1,808 $3,000
Q1 2024

May 14, 2024

SELL
$1.99 - $2.96 $4,021 - $5,982
-2,021 Reduced 57.83%
1,474 $4,000
Q4 2023

Feb 13, 2024

SELL
$1.5 - $2.35 $31,401 - $49,194
-20,934 Reduced 85.69%
3,495 $7,000
Q3 2023

Nov 14, 2023

BUY
$1.75 - $2.52 $9,835 - $14,162
5,620 Added 29.88%
24,429 $51,000
Q2 2023

Aug 14, 2023

BUY
$1.38 - $2.92 $25,956 - $54,922
18,809 New
18,809 $47,000

Others Institutions Holding NXGL

About NEXGEL, INC.


  • Ticker NXGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 5,572,230
  • Market Cap $17.8M
  • Description
  • NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...
More about NXGL
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.